← Back to Search

Temporary changes in an already-implanted medical device (biventricular pacemaker) for Left Ventricular Assist Device Infection

Led By Uma Srivatsa, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Screening 3 weeks
Treatment Varies
Follow Up 2-5 minutes
Awards & highlights


This trial is examining whether or not different settings on a pacemaker can affect the function of an LVAD.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
LVAD flow
LVAD power
LVAD pulsatility index (PI)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CohortExperimental Treatment1 Intervention
Pacemakers will be programmed to BiV pacing, left ventricular (LV) pacing, right ventricular (RV) pacing and no pacing for five minutes each. LVAD flow will be recorded every thirty seconds for five minutes with each setting. Once the interventions have been completed, all pacemakers will be returned to their original setting.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
919 Previous Clinical Trials
4,720,858 Total Patients Enrolled
University of California, San DiegoOTHER
1,135 Previous Clinical Trials
1,551,210 Total Patients Enrolled
Uma Srivatsa, MDPrincipal InvestigatorUC Davis
3 Previous Clinical Trials
27 Total Patients Enrolled
~6 spots leftby Jul 2025